Based on the SMILES CC(C)(C)NC[C@H](O)COc1nsnc1N1CCOCC1, the molecule has a half life time in humans after IV administration of 2.200 hours.
Based on the {SMILES__description} {#representation |!}{SMILES#}, the molecule has a {half_life_duration__names__noun} of {half_life_duration#} {half_life_duration__units}.
(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol